J. Mawdsley

发表

Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors

A. Farmer, Q. Aziz, D. Rampton, 2012, Inflammatory bowel diseases.

The effects of COVID‐19 on IBD prescribing and service provision in a UK tertiary centre

J. Sanderson, M. Samaan, P. Pavlidis, 2020, GastroHep.

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

J. Barrett, M. Tremelling, M. Parkes, 2019, Gastroenterology.

PWE-073 Colonoscopy for a family history of colorectal cancer: are we screening “the worried well”?

I. Beveridge, K. Sundaram, J. Mawdsley, 2012, Gut.

Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

C. Lees, N. Bhala, C. Lamb, 2020, Frontline Gastroenterology.

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO‐LEVEL study

J. Sanderson, M. Samaan, P. Pavlidis, 2020, Alimentary pharmacology & therapeutics.

Lower gastrointestinal bleeding in pregnancy: Differential diagnosis, assessment and management

A. Banerjee, N. Samadi, L. Story, 2020, Obstetric medicine.

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch

M. Samaan, S. Anderson, P. Irving, 2021, Alimentary pharmacology & therapeutics.

Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response

J. Sanderson, M. Samaan, I. Koumoutsos, 2019, Frontline Gastroenterology.

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre

M. Lomer, M. Samaan, P. Pavlidis, 2022, Alimentary pharmacology & therapeutics.

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.

J. Sanderson, E. Dekker, R. Vega, 2019, Journal of Crohn's & colitis.

Synbiotic therapy for ulcerative colitis

D. Rampton, J. Mawdsley, J. Lindsay, 2005, Gut.

An 11‐year experience of enterocutaneous fistula

A. Forbes, P. Hollington, S. Gabe, 2004, The British journal of surgery.

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective

M. Samaan, P. Irving, S. Ray, 2020, Inflammatory bowel diseases.

HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

M. Tremelling, M. Parkes, C. Lees, 2014, Nature Genetics.

An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas

A. Forbes, P. Bassett, P. Hollington, 2008, Alimentary pharmacology & therapeutics.

Technical report: per-oral image-guided insertion of a jejunostomy feeding tube.

A. Forbes, S. Gabe, J. Mawdsley, 2004, Clinical radiology.

Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics

D. Rampton, P. Irving, J. Mawdsley, 2006, European journal of gastroenterology & hepatology.

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.

J. Sanderson, C. Ponsioen, G. D'Haens, 2018, Inflammatory bowel diseases.

Novel presentation of coeliac disease after following the

A. Bateman, J. Mawdsley, N. J. Carr, 2005 .

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

J. Sanderson, M. Samaan, P. Pavlidis, 2020, Inflammatory bowel diseases.

OC-004 Thiopurine Induced Pancreatitis In Inflammatory Bowel Disease: Clinical Features And Genetic Determinants

T. Ahmad, A. Holden, J. Lindsay, 2014, Gut.

Differences in Inflammatory Bowel Disease Phenotype between South Asians and Northern Europeans Living in North West London, UK

S. Marshall, J. Walters, A. Hart, 2011, The American Journal of Gastroenterology.

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study

M. Samaan, P. Pavlidis, S. Anderson, 2022, JGH open : an open access journal of gastroenterology and hepatology.

How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?

M. Samaan, S. Anderson, P. Irving, 2022, Frontline Gastroenterology.

PMO-044 Mortality post percutaneous endoscopic gastrostomy insertion: a root-cause analysis

I. Beveridge, K. Sundaram, J. Mawdsley, 2012, Gut.

Enhanced neoplasia detection in chronic ulcerative colitis: the ENDCaP-C diagnostic accuracy study

M. Parkes, J. Barbour, M. Brown, 2021 .

P340 Risankizumab in Inflammatory Bowel Disease: Real World Experience from a Pre-Approval Access Program

S. Ray, J. Mawdsley, P. Dawson, 2022, Journal of Crohn's and Colitis.

Images of the terminal ileum are more convincing than cecal images for verifying the extent of colonoscopy.

N. Powell, J. Teare, J. Hoare, 2011, Endoscopy.

Buruli ulcer in a visitor to London

J. Mawdsley, K. Rajakulasingam, H. Thangaraj, 2003, The British journal of dermatology.

Appropriateness of Colonoscopy for Patients with Isolated Abdominal Pain

T. Treibel, N. Powell, T. Orchard, 2008 .

Management of orofacial granulomatosis.

B. Carey, J. Mawdsley, M. Ormond, 2023, British journal of hospital medicine.

RECENT ADVANCES IN BASIC SCIENCE PSYCHOLOGICAL STRESS IN IBD: NEW INSIGHTS INTO PATHOGENIC AND THERAPEUTIC IMPLICATIONS

J. Mawdsley, D. Rampton, J E Mawdsley, 2005 .

Capsule endoscopy : do we need it ?

M. Appleyard, J. Mawdsley, 2006 .

Novel thiopurine methyltransferase variant TPMT*28 results in a misdiagnosis of TPMT deficiency.

A. Marinaki, J. Mawdsley, J. Landy, 2011, Inflammatory bowel diseases.